The Cambridge New Therapeutics Forum (CamNTF) is a scientific forum open to all scientists interested in research and development of new therapeutics in Cambridge and the local area.  The purpose of CamNTF is to promote interactions between scientists in order to improve opportunities for biotechnology research and development.

For the second CamNTF event, we will be joined by Dr Xavier Jacq, Head of Biology (MISSION Therapeutics), an experienced drug discovery project manager and expert in protein ubiquitylation and Dr Klaus Okkenhaug, Group Leader (Babraham Institute), an immunologist with particular interests in cell signalling and PI3K-kinases.